# Glaropharm Ag – FDA Inspection, May 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/glaropharm-ag/4567f4cb-ff69-4522-845c-71eba3c7dcc5
Source feed: FDA_Inspections

> FDA inspection 1207105 of Glaropharm Ag, May 31, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207105
- Company Name: Glaropharm Ag
- Inspection Date: 2023-05-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1058998 - 2018-06-15](https://www.keypedia.com/records/fda_inspections/glaropharm-ag/2830e9fa-e332-4204-a292-1d8a08967fef)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-araneta/c94c95f4-2cda-43f5-a02a-2b5d82fe2c7d)
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/glaropharm-ag/c7d66974-1066-4007-909d-51c27de7cc95

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c